Halilibrahim Ciftci received a BSc. in
Chemistry from Ege University, Turkey in 2006 and an M.Sc. in Cancer
Pharmacology from the Institute of Cancer Therapeutics, University of Bradford,
UK in 2008. He worked at major Turkish pharmaceutical companies (i.e., Neutec,
Bilim, and Deva) as an R&D senior scientist to manage all technical aspects
of the product development processes. After working for four years at major
pharmaceutical companies, He returned to his academic career at the School of
Pharmacy at Kumamoto University, Japan in 2012 as a Japanese Government (MEXT)
PhD scholar to develop anti-cancer and anti-HIV drug candidates. He received
his Ph.D. in Pharmaceutical Sciences in 2016 and immediately after, he began
working as a JSPS (Japanese Society for the Promotion of Science) postdoctoral
fellowship at the same school. During his postdoc, he had a close collaboration
with Stanford PULSE Institute for SFX-based drug development. His Research
Keywords include Chemical Biology, Drug Design and Nanoparticles.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
